http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2014265021-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d79362493392629399a529d819cdccd8 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-00 |
filingDate | 2014-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b9ae4ea7d5d50ba8d826c2619157b67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78d13db53d1438f6ae0d4ef50a7be569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc63d12117098da4ceab35ce94c98517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fecd35a2a41fd67470690c851787ece |
publicationDate | 2016-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2014265021-B2 |
titleOfInvention | Prodrugs of nh-acidic compounds |
abstract | The invention provides a method of sustained delivery of a lactam, imide, amide, sulfonamide, carbamate or urea containing parent drug by administering to a patient an effective amount of a prodrug compound of the invention wherein upon administration to the patient, release of the parent drug from the prodrug is sustained release. Prodrug compounds suitable for use in the methods of the invention are labile conjugates of parent drugs that are derivatized through carbonyl linked prodrug moieties. The prodrug compounds of the invention can be used to treat any condition for which the lactam, imide, amide, sulfonamide, carbamate or urea containing parent drug is useful as a treatment. |
priorityDate | 2009-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.